BLKB vs MRNA · P/E 9.1, rev $571.7M vs rev $145.0M
Blackbaud Inc (BLKB) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Blackbaud Inc (BLKB) is a software - application company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported BLKB revenue for 2026-06-30 was $571.7M. Net income was $66.5M. BLKB currently screens at market cap $1.23B and trailing P/E 9.1.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
BLKB currently screens at market cap $1.23B and trailing P/E 9.1. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the BLKB and MRNA stock pages for the full models.
Not investment advice.